Spyridoula Maraka1,2, Naykky M Singh Ospina1,2, Derek T O'Keeffe1, Ana E Espinosa De Ycaza1, Michael R Gionfriddo2,3, Patricia J Erwin4, Charles C Coddington5, Marius N Stan1, M Hassan Murad2,6, Victor M Montori1,2. 1. 1 Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic , Rochester, Minnesota. 2. 2 Knowledge and Evaluation Research Unit, Mayo Clinic , Rochester, Minnesota. 3. 3 Mayo Graduate School, Mayo Clinic , Rochester, Minnesota. 4. 4 Mayo Clinic Libraries, Mayo Clinic , Rochester, Minnesota. 5. 5 Department of Obstetrics and Gynecology, Mayo Clinic , Rochester, Minnesota. 6. 6 Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic , Rochester, Minnesota.
Abstract
BACKGROUND: The impact of subclinical hypothyroidism (SCH) and of levothyroxine replacement in pregnant women with SCH is unclear. The aims of this study were to assess (i) the impact of SCH during pregnancy on maternal and neonatal outcomes, and (ii) the effect of levothyroxine replacement therapy in these patients. METHODS: Ovid MEDLINE In-Process & Other Non-Indexed Citations, Ovid MEDLINE, the Cochrane Controlled Trials Register, Ovid EMBASE, Web of Science, and Scopus were searched from inception to January 2015. Randomized trials and cohort studies of pregnant women with SCH that examined adverse pregnancy and neonatal outcomes were included. Reviewers extracted data and assessed methodological quality in duplicate. Eighteen cohort studies at low-to-moderate risk of bias were included. Compared with euthyroid pregnant women, pregnant women with SCH were at higher risk for pregnancy loss (relative risk [RR] 2.01 [confidence interval (CI) 1.66-2.44]), placental abruption (RR 2.14 [CI 1.23-3.70]), premature rupture of membranes (RR 1.43 [CI 1.04-1.95]), and neonatal death (RR 2.58 [CI 1.41-4.73]). One study at high risk of bias compared pregnant women with SCH who received levothyroxine to those who did not and found no significant decrease in the rate of pregnancy loss, preterm delivery, gestational hypertension, low birth weight, or low Apgar score. CONCLUSIONS: SCH during pregnancy is associated with multiple adverse maternal and neonatal outcomes. The value of levothyroxine therapy in preventing these adverse outcomes remains uncertain.
BACKGROUND: The impact of subclinical hypothyroidism (SCH) and of levothyroxine replacement in pregnant women with SCH is unclear. The aims of this study were to assess (i) the impact of SCH during pregnancy on maternal and neonatal outcomes, and (ii) the effect of levothyroxine replacement therapy in these patients. METHODS: Ovid MEDLINE In-Process & Other Non-Indexed Citations, Ovid MEDLINE, the Cochrane Controlled Trials Register, Ovid EMBASE, Web of Science, and Scopus were searched from inception to January 2015. Randomized trials and cohort studies of pregnant women with SCH that examined adverse pregnancy and neonatal outcomes were included. Reviewers extracted data and assessed methodological quality in duplicate. Eighteen cohort studies at low-to-moderate risk of bias were included. Compared with euthyroid pregnant women, pregnant women with SCH were at higher risk for pregnancy loss (relative risk [RR] 2.01 [confidence interval (CI) 1.66-2.44]), placental abruption (RR 2.14 [CI 1.23-3.70]), premature rupture of membranes (RR 1.43 [CI 1.04-1.95]), and neonatal death (RR 2.58 [CI 1.41-4.73]). One study at high risk of bias compared pregnant women with SCH who received levothyroxine to those who did not and found no significant decrease in the rate of pregnancy loss, preterm delivery, gestational hypertension, low birth weight, or low Apgar score. CONCLUSIONS: SCH during pregnancy is associated with multiple adverse maternal and neonatal outcomes. The value of levothyroxine therapy in preventing these adverse outcomes remains uncertain.
Authors: Karen L Wilson; Brian M Casey; Donald D McIntire; Lisa M Halvorson; F Gary Cunningham Journal: Obstet Gynecol Date: 2012-02 Impact factor: 7.661
Authors: John H Lazarus; Jonathan P Bestwick; Sue Channon; Ruth Paradice; Aldo Maina; Rhian Rees; Elisabetta Chiusano; Rhys John; Varvara Guaraldo; Lynne M George; Marco Perona; Daniela Dall'Amico; Arthur B Parkes; Mohammed Joomun; Nicholas J Wald Journal: N Engl J Med Date: 2012-02-09 Impact factor: 91.245
Authors: Emmy van den Boogaard; Rosa Vissenberg; Jolande A Land; Madelon van Wely; Joris A M van der Post; Mariette Goddijn; Peter H Bisschop Journal: Hum Reprod Update Date: 2011-05-28 Impact factor: 15.610
Authors: Gregory S Y Ong; Narelle C Hadlow; Suzanne J Brown; Ee Mun Lim; John P Walsh Journal: J Clin Endocrinol Metab Date: 2014-12 Impact factor: 5.958
Authors: T I M Korevaar; Arash Derakhshan; Peter N Taylor; Marcel Meima; Liangmiao Chen; Sofie Bliddal; David M Carty; Margreet Meems; Bijay Vaidya; Beverley Shields; Farkhanda Ghafoor; Polina V Popova; Lorena Mosso; Emily Oken; Eila Suvanto; Aya Hisada; Jun Yoshinaga; Suzanne J Brown; Judit Bassols; Juha Auvinen; Wichor M Bramer; Abel López-Bermejo; Colin Dayan; Laura Boucai; Marina Vafeiadi; Elena N Grineva; Alexandra S Tkachuck; Victor J M Pop; T G Vrijkotte; M Guxens; L Chatzi; J Sunyer; A Jiménez-Zabala; I Riaño; M Murcia; X Lu; S Mukhtar; C Delles; U Feldt-Rasmussen; S M Nelson; E K Alexander; L Chaker; T Männistö; J P Walsh; E N Pearce; E A P Steegers; R P Peeters Journal: JAMA Date: 2019-08-20 Impact factor: 56.272
Authors: Spyridoula Maraka; Naykky M Singh Ospina; Derek T O'Keeffe; Rene Rodriguez-Gutierrez; Ana E Espinosa De Ycaza; Chung-Il Wi; Young J Juhn; Charles C Coddington; Victor M Montori Journal: Clin Endocrinol (Oxf) Date: 2016-08-23 Impact factor: 3.478
Authors: Spyridoula Maraka; Raphael Mwangi; Xiaoxi Yao; Lindsey R Sangaralingham; Naykky M Singh Ospina; Derek T O'Keeffe; Rene Rodriguez-Gutierrez; Marius N Stan; Juan P Brito; Victor M Montori; Rozalina G McCoy Journal: J Clin Endocrinol Metab Date: 2019-04-24 Impact factor: 5.958
Authors: Theodora Pappa; João Anselmo; Sunnee Mamanasiri; Alexandra M Dumitrescu; Roy E Weiss; Samuel Refetoff Journal: J Clin Endocrinol Metab Date: 2017-10-01 Impact factor: 5.958
Authors: Sophie A H Boesen; Manhai Long; Maria Wielsøe; Vicente Mustieles; Mariana F Fernandez; Eva C Bonefeld-Jørgensen Journal: Environ Health Date: 2020-10-13 Impact factor: 5.984
Authors: Spyridoula Maraka; Naykky M Singh Ospina; Derek T O'Keeffe; Rene Rodriguez-Gutierrez; Ana E Espinosa De Ycaza; Chung-Il Wi; Young J Juhn; Charles C Coddington; Victor M Montori; Marius N Stan Journal: Thyroid Date: 2016-05-16 Impact factor: 6.568